This course on polyketide biosynthesis and the development of anti-ulcer drugs starts with a concise discussion of secondary metabolites as well as the biosynthesis of macrolide polyketides in connection to erythromycin and their characteristic features. Next, you will be introduced to viruses and the design strategy of anti-viral drugs. This will follow with a look at the chemistry and biology of cancer, anticancer agents, aromatase inhibition and anti-ulcer drugs.

You will then be introduced to hypertension, which is a cholesterol-related illness and the biosynthesis of cholesterol. You will also be introduced to the next stage in the drug validation process after the preclinical trials, which is the study of the drug pharmacokinetics and pharmacodynamics properties as well as QSAR (quantitative structure-activity relationship) principles and their importance.

This course will be of great interest to professionals working in the pharmaceutical industry such as chemists, biochemists, chemical biologists and pharmacists. It will equally benefit any learner who would like to have a career in the pharmaceutical sector. So, check out the course now and kickstart an exciting career in the field of drug development today.